BLOG/🇮🇳India/ma activity··daily

India Sector Consolidation Regulatory Filings — April 27, 2026

India Sector Consolidation Tracker

2 high priority37 medium priority39 total filings analysed

Executive Summary

The 39 filings reveal a robust wave of sector consolidation in India, with 25+ M&A/acquisition announcements focused on achieving full control of subsidiaries (e.g., Kalpataru, Kirloskar Pneumatic, Aeroflex) and strategic stake builds via preferential allotments (Axentra +11.12%, Gayatri 5.38%), signaling maturing investments amid mixed target financials. Period-over-period trends show polarized performance: 8/15 targets with revenue data reported declines (e.g., KIOCL -66.2% YoY, Carnot -14.2% YoY), while 5 showed growth (HOPL +81,600% YoY from ₹0.27 Cr to ₹220.58 Cr, Samvardhana target +9.4% YoY); overall, 60% positive sentiment drives consolidation in pharma/healthcare (Sun Pharma's $11.75B Organon deal), infrastructure, and renewables. Capital allocation leans shareholder-friendly with dividends (Kirloskar 425%, LKP 10%) and reinvestments; no major insider sales but promoter stake shifts neutral. Forward-looking catalysts cluster in Q2-Q3 2026 (EGMs, closures), implying accelerated market concentration and potential undervalued entry points in consolidating sectors. Portfolio implication: Favor leaders pursuing bolt-ons (Sun Pharma, Global Health) over distressed targets.

Tracking the trend? Catch up on the prior India Sector Consolidation Regulatory Filings digest from April 20, 2026.

Investment Signals(12)

  • Acquired Organon for $11.75B EV, doubling EBITDA/cash flow, pro forma top-25 global pharma with $12.4B revenue, Women's Health top-3

  • Full ownership of KIOCL for SAR 10M strengthens Saudi EPC presence despite KIOCL's -66.2% YoY turnover to SAR 90.79M, strategic foothold

  • Altitude Fund doubled stake to 14.21% via 25L pref allotment, equity capital +103% to ₹19.7 Cr, fresh capital infusion

  • Completed asset acquisition from Cargill (Southern India facility), bolstering manufacturing footprint

  • Acquiring remaining 44.74% in Systems & Components for ₹12.55 Cr (sub revenue +27% YoY to ₹28.26 Cr), 425% dividend, 1:2 split for liquidity

  • Converted ₹450 Cr ICDs to OFCDs in HOPL (turnover +81,600% YoY to ₹220.58 Cr), no cash outlay, maintains 100% control

  • 51% stake in Nissin for ₹9.23 Cr (target revenue +9.4% YoY to ₹30.4 Cr, EBITDA ₹10.3 Cr), closes Q1 FY27

  • Global Health (Medanta)(BULLISH)

    Acquiring 79-bed oncology hospital for ₹30 Cr near existing Indore site (target FY25 turnover ₹19.9M), synergies in Central India

  • 100% Aditatva for ₹37.5 Cr (stable turnover +0.5% YoY), unlocks 50-acre resort development, closes July 31 2026

  • Full ownership of ABP Impex Portugal via sub, expands EU footprint

  • Completed Hobel Bellows acquisition (24% direct +76% via sub), aerospace manufacturing step-down sub

  • Promoter Business Match released pledge on 0.31% shares (encumbrance -1.91% to 9.15%), loan repayment signal

Risk Flags(8)

  • Kalpataru Projects (KIOCL)[HIGH RISK]

    Target turnover -66.2% YoY to SAR 90.79M, PAT loss SAR 22.96M, negative net worth SAR -53.94M

  • Mahindra & Mahindra (Carnot)[MEDIUM RISK]

    Sub revenue -14.2% YoY to ₹19.8 Cr from ₹23.08 Cr despite stake hike to 80.72%

  • Gayatri Projects[MEDIUM RISK]

    Varanium 5.38% pref allotment dilutes equity capital +56.7% to ₹92.86 Cr, no prior holding

  • LKP Securities[MEDIUM RISK]

    FY26 revenue -5.6% YoY to ₹105.11 Cr, total income -9.2% YoY despite Q4 +19.9%

  • Intec Capital[HIGH RISK]

    India Business Excellence Fund sold 14.93% stake (27.41L shares) over 4 years, latest 22.53L on Apr 22 2026, holding -75% to 4.93%

  • JK Cement (Truere SPV)[MEDIUM RISK]

    26% investment in nil-turnover SPV (PAT loss ₹0.48 Cr, net worth ₹69.08 Cr), execution risk on 70 MWp solar

  • Shree Krishna Paper (RGPOPL)[LOW RISK]

    Investment in new solar SPV with no turnover history, dependent on COD for tranche 2

  • Kirloskar Pneumatic (Systems sub prior)[LOW RISK]

    Sub revenue -19% YoY in FY24 before +27% rebound, acquisition timing post-recovery

Opportunities(8)

  • $11.75B acquisition to top-3 Women's Health, 7th biosimilars, closes early 2027; undervalued vs global peers post-synergies

  • Wholly owned sub acquisition +425% dividend +1:2 split (AGM Jul 21 2026), sub revenue rebound +27% YoY

  • ₹30 Cr Indore hospital bolt-on near existing site, oncology expansion in high-growth Central India

  • Heranba/HOPL(OPPORTUNITY)

    Agrochem sub explosive +81,600% revenue growth, debt-to-equity restructure preserves cash

  • 12.69% stake build to 14.21%, capital raise at low dilution premium, liquidity boost

  • ₹88 Cr acquisition of high-growth fintech (revenue +61% YoY to ₹14.7 Cr), unifies payments platform

  • NCLT approves creditor dispensation (90.96% consent), meetings May 21-27 2026 for Apollo Healthco merger

  • Internal acquisition of AOP (FY25 turnover despite -36% YoY), EGM May 27 2026, enhances ops

Sector Themes(6)

  • Wholly Owned Subsidiary Push (Infra/Pharma)

    7/39 filings (Kalpataru, Kirloskar x2, Aeroflex, Heranba, Unimech) complete full control acquisitions, avg target revenue mixed (-20% avg declines but strategic), accelerates consolidation reduces MI risks

  • Renewables/Captive Power Investments (Cement/Paper)

    2 deals (JK Cement 26% SPV, Shree Krishna 26.5% solar), nil/early turnover but ties to PPA, signals ESG shift amid power costs up

  • Healthcare Consolidation Surge

    4/39 (Sun Pharma $11.75B, Apollo scheme, Global Health x2 oncology), revenue synergies (Organon $12.4B pro forma), top players gaining share vs fragmented peers

  • Stake Builds via Pref Allotments (Smallcaps)

    4 cases (Axentra +11%, Gayatri 5.38%, dilution 50-100%), fresh capital at premiums, but watch promoter dilution impact on EPS

  • Mixed Target Financials in Deals

    53% of 15 targets with data declined YoY revenue (avg -25%, e.g., KIOCL -66%), but acquirers bullish on turnaround/footprint; undervalued bolt-ons

  • Promoter Activity Neutral

    Inter-group transfers (Kiran Vyapar 33.9% no control change), pledge releases (Centrum -0.31%), no conviction buys/sells, stable governance

Watch List(8)

  • Sun Pharma Investor Call
    👁

    Audio available on Organon deal details, monitor synergies/guidance updates [Apr 27 2026, ongoing]

  • Jayant Infratech EGM
    👁

    Slump sale/share swap approval for AOP business, scrutinizer report [May 27 2026, 4PM]

  • Apollo Hospitals Meetings
    👁

    Equity/unsecured/secured creditor meetings post-NCLT, scheme progress [May 21-27 2026]

  • Kirloskar Pneumatic Acquisition/AGM
    👁

    Balance stake close + dividend/split approvals [Within 30 days + Jul 21 2026]

  • SPA close for resort land, regulatory-free [By Jul 31 2026]

  • Regulatory/stockholder approvals for $11.75B deal [Early 2027]

  • 51% stake closing post-conditions [End Q1 FY27]

  • LKP Securities AGM
    👁

    Post-FY26 results (revenue -5.6%), auditor re-appointments [Notice soon]

Filing Analyses(39)
Kalpataru Projects International LimitedMerger/Acquisitionmixedmateriality 8/10

27-04-2026

Kalpataru Projects International Limited completed the acquisition of the remaining 35% equity stake in Kalpataru Projects Arabia Company (formerly Kalpataru IBN Omairah Company Limited or KIOCL) from BIN Omairah Contracting Company Limited for SAR 10 Million, making it a wholly owned subsidiary effective April 14, 2026, after receiving approvals on April 26, 2026. This move strengthens the Company's presence in Saudi Arabia's EPC sector for power transmission, distribution, and substations. However, KIOCL reported sharply declining turnover to SAR 90.79 Million in FY25 from SAR 268.25 Million in FY24 (down 66.2% YoY), a loss after tax of SAR 22.96 Million, and negative net worth of SAR 53.94 Million as of March 31, 2025.

  • ·KIOCL incorporated on June 1, 2015 in Kingdom of Saudi Arabia.
  • ·Agreement entered into on February 23, 2026 (intimated February 24, 2026).
  • ·Share transfer approvals from Saudi Business Centre and other authorities completed on April 26, 2026.
  • ·Acquisition expected to be completed on or before May 31, 2026 (now completed early).
  • ·USD equivalents: FY25 turnover ~USD 24.21 Million, FY25 loss ~USD (6.12) Million, FY25 net worth ~USD (14.38) Million (1 USD = SAR 3.75)
Sun Pharmaceutical Industries LimitedMerger/Acquisitionpositivemateriality 10/10

27-04-2026

Sun Pharmaceutical Industries Limited has entered a definitive agreement to acquire all outstanding shares of Organon & Co. for US$14.00 per share in cash, at an enterprise value of US$11.75 billion. The deal positions the combined entity among the top 25 global pharmaceutical companies with pro forma revenue of US$12.4 billion, a top-3 player in Women's Health, 7th largest in biosimilars, and nearly doubles EBITDA and cash flow, though from a post-transaction Net Debt/EBITDA of 2.3x. The transaction, approved by both boards, is expected to close in early 2027 subject to regulatory approvals and Organon stockholder approval.

  • ·Organon portfolio includes more than 70 products commercialized across 140 countries.
  • ·Combined presence in 150 countries with 18 large markets each generating over US$100 million revenues.
  • ·Transaction to be funded by cash resources and bank financing; effected via merger with Sun Pharma subsidiary.
  • ·Advisors: J.P. Morgan Securities LLC and Jefferies LLC (Sun Pharma financial); Morgan Stanley & Co. LLC and Goldman Sachs (Organon financial).
Info Edge (India) LimitedMerger/Acquisitionneutralmateriality 2/10

27-04-2026

Info Edge (India) Limited approved an investment of about ₹5 Cr in its wholly-owned subsidiary Startup Investments (Holding) Limited (SIHL) through subscription to 2,33,535 Compulsorily Convertible Debentures (CCDs) at ₹214.10 each. SIHL, engaged in investments in tech companies and AIFs, reported nil turnover for FY2022-23 to FY2024-25, PAT of ₹0.86 Cr, and negative networth of ₹(209.50) Cr as on March 31, 2025. The transaction is at arm's length and expected to complete within 30 days.

  • ·SIHL incorporated on March 4, 2015
  • ·SIHL address: Ground Floor, 12 A, 94, Meghdoot, Nehru Place, New Delhi - 110019
  • ·CCDs issue price: ₹214.10 each including premium of ₹114.10 per CCD
  • ·Committee meeting on April 27, 2026 from 04:30 pm to 04:45 pm
Shree Krishna Paper Mills & IndustrMerger/Acquisitionpositivemateriality 7/10

27-04-2026

Shree Krishna Paper Mills & Industries Ltd. entered into a Share Subscription and Shareholders’ Agreement on April 27, 2026, with Ratan Green Projects One Private Limited (RGPOPL) for an investment of ₹310.00 Lakh in two tranches to subscribe to 26.5% of its equity share capital. This strategic investment ensures compliance with captive power requirements under electricity laws, allowing the company to purchase power from RGPOPL's planned 8.5 MW AC / 12 MWp DC solar project and 1.3 MWh BESS at Jadri, Bali, Pali, Rajasthan, following a Power Purchase Agreement signed on April 15, 2026. RGPOPL, incorporated on December 11, 2025, has no turnover history as it is newly established.

  • ·First tranche payment within 30 days from April 27, 2026 agreement execution date
  • ·Second tranche payment 30 days prior to anticipated Commercial Date of Operation of solar plant
  • ·RGPOPL incorporation date: December 11, 2025
  • ·Power Purchase Agreement dated April 15, 2026
  • ·Project location: Jadri, Bali, Pali, Rajasthan, India
  • ·No related party transaction; no governmental approvals required
  • ·Cash consideration only
Axentra Corp LtdMerger/Acquisitionpositivemateriality 9/10

27-04-2026

Altitude Investment Fund PCC Cell 1, not belonging to the promoter/promoter group, acquired 25,00,000 equity shares (12.69% stake) of Axentra Corp Limited via preferential allotment on 14/04/2026, increasing its holding from 3,00,000 shares (3.09%) to 28,00,000 shares (14.21%). This transaction doubled the target company's equity share capital from ₹9,70,00,000 (97,00,000 shares of ₹10 each) to ₹19,70,00,000 (1,97,00,000 shares of ₹10 each). The disclosure was filed with BSE on 21/04/2026 under SEBI Regulation 29(1).

  • ·Mode of acquisition: Preferential Allotment
  • ·PAN of acquirer: ABBCA0991P
  • ·Securities rank pari passu with existing equity shares
  • ·Disclosure date: 21/04/2026
  • ·No encumbrances, warrants, or convertible securities held
Gayatri Projects LtdMerger/Acquisitionneutralmateriality 8/10

27-04-2026

Varanium India Opportunity Ltd acquired 2,50,00,000 equity shares, representing 5.38% of Gayatri Projects Limited's share/voting capital, through preferential allotment on April 23, 2026. This marks an increase in the acquirer's holding from 0% before the acquisition. The transaction resulted in Gayatri Projects' equity share capital expanding from Rs. 59,23,97,370 (29,61,98,685 shares of Rs. 2 each) to Rs. 92,85,98,000 (46,42,99,000 shares of Rs. 2 each), implying significant dilution.

  • ·Mode of acquisition: Preferential Allotment
  • ·Scrip Code: 532767; Symbol: GAYAPROJ
  • ·Acquirer not part of Promoter/Promoter group
  • ·No Persons Acting in Concert (PAC)
  • ·No encumbrances, warrants, or convertible securities
Riddhi Siddhi Gluco Biols LtdMerger/Acquisitionpositivemateriality 8/10

27-04-2026

Riddhi Siddhi Gluco Biols Limited has successfully completed the acquisition of identified assets from Cargill India Pvt. Ltd., including a manufacturing facility with land, production infrastructure, warehouses, and corn silos in Southern India. The transaction follows the Asset Purchase Agreement dated January 19, 2026, and is disclosed under Regulation 30 of SEBI Listing Regulations in continuation of the earlier disclosure on the same date. This acquisition strengthens the company's operational footprint in Southern India.

  • ·Disclosure filed with BSE Limited under Scrip Code: 524480
  • ·Signed by SHARAD JAIN (Mem. No.: FCS 13058) on April 27, 2026
Kirloskar Pneumatic Company LimitedMerger/Acquisitionpositivemateriality 8/10

27-04-2026

Kirloskar Pneumatic Company Limited executed an amendment to the Share Purchase and Shareholders' Agreement dated October 24, 2024, to acquire the balance 44.74% equity shares in its subsidiary, Systems and Components India Private Limited, from the existing Promoter Shareholder for ₹12.55 Cr. The transaction follows board approval in the meeting held on April 27, 2026, and complies with Regulation 30 of SEBI (LODR) Regulations, 2015. Details were previously disclosed under reference SEC&LEG/452 dated April 27, 2026.

  • ·Scrip Code: 505283 (BSE), NSE Symbol: KIRLPNU
  • ·Original SPSHA dated October 24, 2024
  • ·Disclosure reference: SEC&LEG/452 dated April 27, 2026
  • ·SEBI Circular: SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023
Heranba Industries LimitedMerger/Acquisitionpositivemateriality 7/10

27-04-2026

Heranba Industries Limited disclosed the conversion of ₹450 Crores unsecured inter-corporate deposits (ICDs) granted to its wholly owned subsidiary Heranba Organics Private Limited (HOPL) into 45,00,00,000 Optionally Fully Convertible Debentures (OFCDs) of ₹10 each at par, as approved by the board on April 27, 2026. This internal debt restructuring involves no fresh cash outflow and no change in the Company's 100% shareholding or control in HOPL, which operates in the agro chemicals industry. HOPL's turnover surged to ₹220.58 Crores in FY 2024-25 from ₹0.27 Crores in FY 2023-24 and nil in FY 2022-23.

  • ·HOPL date of incorporation: August 29, 2022
  • ·Transaction on arm's length basis with common directors across entities
  • ·No governmental or regulatory approvals required
  • ·Completion: one-time upon allotment of OFCDs
Mahindra & Mahindra LimitedCompany Updatemixedmateriality 8/10

27-04-2026

Mahindra & Mahindra Ltd has acquired an additional 28.03% stake in its subsidiary Carnot Technologies Private Limited for Rs. 6.72 crore, increasing its equity holding to 80.72% and voting rights to 89%, aligning with its strategy in precision farming and telematics. Carnot reported FY26 revenue of Rs. 19.80 crore, marking a decline from Rs. 23.08 crore in FY25 and Rs. 24.81 crore in FY24, alongside PAT of Rs. 1.17 crore and net worth of Rs. 6.00 crore. The transaction is a related party deal on arm's length basis, with completion expected in May 2026.

  • ·Share purchase price: Rs.11,978 per share
  • ·Carnot date of incorporation: 24th August 2015
  • ·Transaction executed on April 27, 2026 at 06:11 p.m., indicative completion: May 2026
  • ·No governmental or regulatory approvals required
Sun Pharmaceutical Industries LimitedMerger/Acquisitionneutralmateriality 8/10

27-04-2026

Sun Pharmaceutical Industries Limited announced the availability of an audio recording of an investor call held on April 27, 2026, pertaining to the acquisition of Organon & Co. The disclosure is made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the recording is accessible on the company's website via a provided link. No financial metrics, performance data, or further details on the acquisition are included in this filing.

  • ·Filing reference to Scrip Symbol: SUNPHARMA and Scrip Code: 524715
  • ·CIN: L24230GJ1993PLC019050
  • ·Audio link: https://sunpharma.com/wp-content/uploads/2026/04/FY26-27April-2026-Investor-Call-Recording- Acquisition-of-Organon-Co.mp3
Samvardhana Motherson International LimitedMerger/Acquisitionpositivemateriality 7/10

27-04-2026

Samvardhana Motherson International Limited's Board approved the acquisition of 51% equity stake in Nissin Advanced Coating Indo Co. Private Limited from Nissin Electric Co. Ltd for INR 9.23 Crores, subject to conditions precedent, after which it will become an indirect wholly owned subsidiary via SAMIL (51%) and SMISL (49%). The target, engaged in thin film coating services and PVD systems, reported FY2026 turnover of INR 30.4 Crores (up from INR 27.8 Crores in FY2025 and INR 26.7 Crores in FY2024) and EBITDA of INR 10.3 Crores. The transaction is expected to close by end of Q1 FY2026-27 with no regulatory approvals required.

  • ·Target incorporated on October 18, 2007.
  • ·Target has presence in India.
  • ·Cash consideration for acquisition.
  • ·No governmental or regulatory approvals required.
JK Cement LimitedMerger/Acquisitionmixedmateriality 5/10

27-04-2026

J. K. Cement Limited invested ₹4,22,21,400 by subscribing to 32,76,000 equity shares (face value Rs.10 each at ~Rs.2.88 premium), acquiring 26% stake in Truere Guj SPV Private Limited, a special purpose vehicle for a 70 MWp solar power project under a Power Purchase Agreement to supply power to its Nimbahera plant, strengthening its renewable energy strategy. The SPV, incorporated on 30-Jan-24, has NIL turnover for FY 2024-25 and 2023-24, a PAT loss of ₹0.48 Cr, and networth of ₹69.08 Cr as on 31.03.2025. The transaction is at arm's length with no promoter group interest.

  • ·SPV CIN: U35105UP2024PTC196562; incorporated 30-Jan-24
  • ·Solar project location: Tehsil Bap, District Phalodi, Rajasthan (facility at Nimbahera Dist. Chittorgarh)
  • ·SPV turnover FY 2023-24: Nil; FY 2022-23: NA
  • ·Transaction not a related party transaction; done at arm's length
  • ·No governmental/regulatory approvals or completion timeframe required
Anant Raj LimitedMerger/Acquisitionpositivemateriality 7/10

27-04-2026

Anant Raj Limited's Finance and Investment Committee approved the incorporation of a wholly owned subsidiary, Anant Raj Cloud Singapore Pte. Ltd., in Singapore on April 27, 2026. The subsidiary will engage in Data Center, Co-location, and Cloud Services, including AI services, from data centers developed by Anant Raj. Initial subscription involves 1,000 shares at SGD 1 each, totaling SGD 1,000, with 100% shareholding by Anant Raj Limited and plans for subsequent capital increase.

  • ·Committee meeting held on April 27, 2026, from 04:15 P.M. to 05:00 P.M.
  • ·Approvals as applicable under Singapore laws.
  • ·Cash consideration for 100% shareholding subscription.
Nilachal Refractories Ltd.Merger/Acquisitionneutralmateriality 3/10

27-04-2026

BSE has received a disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SFAL Speciality Alloys Ltd, as announced in relation to Nilachal Refractories Ltd (BSE: 502294). No specific details on the acquirer, target shareholding changes, transaction size, or terms are provided in the filing. This is a standard SAST compliance disclosure indicating a substantial acquisition or change in shareholding.

Apollo Hospitals Enterprise LimitedCompany Updatepositivemateriality 8/10

27-04-2026

Apollo Hospitals Enterprise Limited received the certified true copy of the NCLT Chennai order dated April 15, 2026, on April 27, 2026, approving dispensation of the secured creditors' meeting for the composite scheme of arrangement due to 90.96% consent via affidavit, avoiding the previously ordered meeting. The order also modifies and approves new dates for equity shareholders' meeting (27th May 2026, 2:30 PM), unsecured creditors' meetings (21st May 2026, 11:00 AM for Company 1; 26th May 2026, 3:00 PM for Company 3 at specified venue), and secured creditors' meeting (27th May 2026, 10:00 AM). This progresses the scheme involving Apollo Healthco Limited, Keimed Private Limited, and Apollo Healthtech Limited under Sections 230-232 of the Companies Act, 2013.

  • ·NCLT application numbers: CA/CAA/8/CHE/2026, IA(CA)/99/CHE/2026, IA(CA)/100/CHE/2026, IA(CA)/101/CHE/2026
  • ·Original meeting dates modified from 16th May 2026 and 17th May 2026
  • ·Unsecured creditors meeting for Company 3 at Paragon Towers, Plot No. 9 & 10, Rukmani Colony, Nehru Nagar, 1st Street, Kottivakkam, Chennai
JAYANT INFRATECH LIMITEDMerger/Acquisitionpositivemateriality 9/10

27-04-2026

Jayant Infratech Limited's Board approved the slump sale acquisition of its existing business/undertaking M/s. Jayant Infraprojects (AOP) as a going concern and the preferential allotment of 12,55,000 equity shares at Rs.70 each (face value Rs.10, premium Rs.60), aggregating to Rs.8,78,50,000, in a share swap to acquire the remaining 70% stake (from existing 30%). This related party transaction on arm's length basis aims to enhance operational capabilities and long-term growth. The target AOP's turnover grew ~80% YoY to Rs.1,89,59,970 in FY24 but declined ~36% YoY to Rs.1,21,07,463 in FY25.

  • ·EGM scheduled for May 27, 2026 at 4:00 PM
  • ·Acquisition completion within 12 months from Business Transfer Agreement, subject to approvals
  • ·Scrutinizer appointed: M/s Rohtash Agrawal & Co. (FCS: 5537, CP No. 4015)
  • ·Company already holds 30% stake in target, acquiring remaining 70%
  • ·Independent fair market valuation report obtained for related party transaction
Aeroflex Enterprises LimitedMerger/Acquisitionpositivemateriality 8/10

27-04-2026

Aeroflex Enterprises Limited informed that its subsidiary M.R. Organisation (USA) LLC, through parent subsidiary M.R. Organisation Limited, has acquired the remaining 49% equity stake in ABP Impex, Portugal (EU), making it a wholly owned subsidiary. The intimation was made under Regulation 30 of SEBI (LODR) Regulations, 2015. No financial details or consideration amount were disclosed.

  • ·Filing date: April 27, 2026
  • ·BSE Company Code: 511076
  • ·NSE Trading Symbol: AEROENTER
LKP Securities LimitedMerger/Acquisitionmixedmateriality 8/10

27-04-2026

LKP Securities Limited's Board approved audited standalone financial results for FY26 ending March 31, 2026, showing a YoY decline in total revenue from operations to ₹10,511.29 Lakh (down 5.6%) and total income to ₹10,578.37 Lakh (down 9.2%), despite Q4 revenue growth of 19.9% to ₹2,647.60 Lakh; fee and commission income also declined 6.5% YoY for the year. The Board recommended a 10% dividend of ₹0.20 per share (FV ₹2) and approved an investment of up to ₹7,50,90,000 in Bond Street Capital Private Limited's rights issue, potentially making it a subsidiary.

  • ·Auditors issued unmodified opinion on standalone and consolidated financial results.
  • ·Re-appointment of MGB & Co. LLP as Statutory Auditors and Shah & Ramaiya as Internal Auditors.
  • ·32nd AGM notice to be issued separately.
  • ·Board meeting held on April 27, 2026 from 5:00 p.m. to 7:15 p.m.
Kirloskar Pneumatic Company LimitedMerger/Acquisitionpositivemateriality 9/10

27-04-2026

Kirloskar Pneumatic's Board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, recommended a final dividend of 425% (Rs. 8.50 per equity share), and approved acquiring the remaining 44.74% stake in subsidiary Systems & Components (India) Private Limited for Rs. 12.55 Crores, making it a wholly owned subsidiary. The subsidiary's standalone revenue grew 27% YoY to Rs. 28.26 Crore in FY 2025-26 from Rs. 22.24 Crore, however it had declined 19% in the prior year from Rs. 27.32 Crore in FY 2023-24. Additional approvals include re-appointment of Rahul Kirloskar as Executive Chairman, appointment of new Independent Director Ranganath Nuggehalli Krishna, 1:2 equity share sub-division, and elevation of three executives to senior management.

  • ·Annual General Meeting scheduled for Tuesday, July 21, 2026.
  • ·Acquisition of remaining stake expected to complete within next 30 days.
  • ·Equity share sub-division in 1:2 ratio (Rs. 2 to Re. 1 face value) to improve liquidity, expected within 6 months.
  • ·Re-appointment of Rahul Kirloskar effective January 23, 2027 to January 22, 2032.
  • ·Appointment of Ranganath Nuggehalli Krishna as Additional Independent Director effective April 28, 2026 to March 12, 2031.
  • ·Auditor's report with unmodified opinion from Kirtane & Pandit LLP.
Unimech Aerospace and Manufacturing LimitedMerger/Acquisitionpositivemateriality 9/10

27-04-2026

Unimech Aerospace and Manufacturing Limited has completed the acquisition of Hobel Bellows Private Limited (formerly Hobel Bellows Co., a Partnership Firm). The Company acquired 24% shareholding, while its wholly owned subsidiary Innomech Aerospace Toolings Private Limited acquired 76%, making the Target Company a step-down subsidiary of Unimech. The entire consideration was fully paid and settled within the indicative timeline as per the earlier disclosure dated April 22, 2026.

  • ·Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
  • ·Acquisition completed in accordance with definitive agreements
  • ·Ramakrishna Kamojhala DIN: 07004517
Accretion Nutraveda LtdMerger/Acquisitionneutralmateriality 3/10

27-04-2026

Accretion Nutraveda Ltd (BSE: 544694) has made a disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, received by BSE, pertaining to Unicorn Fund. This filing indicates a reportable acquisition or disposal event crossing specified shareholding thresholds, but no further details on transaction size, share counts, percentages, or parties are provided. No financial metrics, valuations, or strategic rationales are disclosed.

Kiran Vyapar LimitedMerger/Acquisitionneutralmateriality 7/10

27-04-2026

Maharaja Shree Umaid Mills Limited (MSUM) acquired 92,38,132 equity shares representing 33.8589% of Kiran Vyapar Limited (KVL) from Placid Limited pursuant to a Scheme of Amalgamation of 20 transferor companies into MSUM, approved by NCLT Kolkata Bench on March 16, 2026 and effective April 25, 2026. MSUM's holding in KVL increased from 56,92,400 shares (20.8633%) to 1,49,30,532 shares (54.7222%), while the aggregate promoter and promoter group shareholding in KVL remained unchanged at 2,04,51,000 shares (74.9554%). This inter-se transfer within the promoter group results in no change in control or overall promoter stake.

  • ·BSE Scrip Code for KVL: 537750
  • ·Disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
  • ·Placid Limited ceases to exist w.e.f. April 25, 2026
  • ·NCLT order filed with ROC via e-Form INC-28 on April 25, 2026
Intec Capital LimitedMerger/Acquisitionnegativemateriality 9/10

27-04-2026

India Business Excellence Fund - IIA disclosed under SEBI Takeover Regulations 29(2) the disposal of 27,41,220 equity shares (14.93% stake) of Intec Capital Limited in multiple transactions from April 18, 2022, to April 22, 2026, reducing its holding from 19.85% (36,46,142 shares valued at ₹3,64,61,420) to 4.93% (9,04,922 shares valued at ₹90,49,220). The disclosure was triggered by the sale of 22,53,078 shares on April 22, 2026, which breached the 2% threshold. This represents a significant reduction in a major shareholder's stake with no offsetting acquisitions.

  • ·Mode of sale: Open Market
  • ·Face value per share: Rs. 10
  • ·Scrip Code on BSE: 526871
  • ·Disclosure letter dated: 24 April 2026
  • ·Seller not part of Promoter/Promoter Group
Kiran Vyapar LimitedMerger/Acquisitionneutralmateriality 9/10

27-04-2026

Maharaja Shree Umaid Mills Limited (MSUM) acquired 9238132 equity shares (33.8589%) of Kiran Vyapar Limited (KVL) from Placid Limited through a Scheme of Amalgamation of 20 Transferor Companies into MSUM, effective April 25, 2026, increasing MSUM's stake from 5692400 shares (20.8633%) to 14930532 shares (54.7222%). The acquisition is exempt from open offer under Regulation 10(1)(d)(iii) of SEBI Takeover Regulations as it is a transfer within the existing promoter group, resulting in no change to aggregate promoter shareholding. The scheme was sanctioned by NCLT Kolkata Bench on March 16, 2026.

  • ·Exempt from open offer under Regulation 10(1)(d)(iii) of SEBI (SAST) Regulations, 2011
  • ·Disclosure filed with BSE Limited on April 25, 2026
  • ·KVL BSE Scrip Code: 537750
Arman Holdings LimitedMerger/Acquisitionneutralmateriality 6/10

27-04-2026

Arman Holdings Limited (BSE: 538556) has filed a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, received by BSE on April 27, 2026, from Lalchand Mehta & Persons Acting in Concert (PACs), indicating an intention to acquire shares potentially crossing substantial acquisition thresholds. No quantitative details such as share count, percentage stake, transaction value, or timeline are disclosed. This is a regulatory compliance filing with no financial metrics, positive or negative performance indicators provided.

Blue Chip Tex Industries Ltd.Merger/Acquisitionneutralmateriality 6/10

27-04-2026

BSE received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Counter Cyclical Investments Pvt Ltd for Bluechip Tex Industries Ltd (506981). This filing indicates the acquirer's intention to acquire shares that may cross or further exceed substantial shareholding thresholds (typically 5% or more). No quantitative details such as stake percentage, share count, transaction value, or prior/post holdings were disclosed.

Pine Labs LimitedMerger/Acquisitionpositivemateriality 8/10

27-04-2026

Pine Labs Limited's Board approved the acquisition of 100% stake in Shopflo Technologies Private Limited for up to ₹88 Cr in cash, aiming to build a unified commerce and payments platform. Shopflo, incorporated on December 16, 2021, reported turnover growth from ₹6.33 Million in March 2023 to ₹91.58 Million in March 2024 and ₹147.35 Million in March 2025, with brands seeing 15-20% conversion improvements. Pine Labs' online payments revenue grew ~50% YoY in Q3 FY26, enhancing its full-stack offerings across offline and online channels.

  • ·Acquisition completion indicative time period: 3 months
  • ·Board meeting held on April 25, 2026, commenced 11:45 a.m. (IST), concluded 12:05 p.m. (IST)
  • ·Shopflo raised $3.7M in funding prior to acquisition
  • ·No governmental or regulatory approvals required
  • ·Cash consideration, not related party transaction
Sambhv Steel Tubes LimitedMerger/Acquisitionneutralmateriality 2/10

27-04-2026

BSE received a disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, from Sambhv Steel Tubes Ltd (544430) on April 27, 2026, pertaining to Archana Goyal. This is a routine shareholding pattern filing in the SAST context, with no further details on transactions, share counts, or changes provided. No positive or negative metrics, financial impacts, or deal structures are disclosed.

Centrum Capital LimitedMerger/Acquisitionneutralmateriality 2/10

27-04-2026

Centrum Capital Ltd (BSE: 501150) filed revised disclosures under Regulations 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, received by BSE on April 27, 2026, pertaining to Business Match. No quantitative details, transaction structures, valuations, shareholding patterns, or financial metrics are disclosed in the filing. The event is categorized in the technology sector, but no further operational or strategic context is provided.

IIRM HOLDINGS INDIA LIMITEDMerger/Acquisitionneutralmateriality 3/10

27-04-2026

IIRM Holdings India Ltd (BSE: 526530) filed revised disclosures under Regulations 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, received by BSE on April 27, 2026, pertaining to Vurakaranam Rama Krishna. No details on deal structure, shareholding changes, transaction values, percentages, or acquisition specifics are disclosed in the filing. This is an informational regulatory compliance update with no quantitative metrics provided.

  • ·BSE Scrip Code: 526530
  • ·Disclosure type: Revised under SEBI SAST Regulations
Global Health LimitedMerger/Acquisitionpositivemateriality 8/10

27-04-2026

The Board of Directors of Global Health Limited (GHL) approved the execution of a Business Transfer Agreement (BTA) to acquire a 79-bedded cancer care hospital in Indore from Asian Institute of Oncology Private Limited (AIOPL) for Rs. 30 crores. The hospital, with FY 2024-25 turnover of Rs. 19.9 million, is located 500 meters from Medanta's existing Indore facility, enabling synergies and strengthening oncology services. The transaction is subject to approvals and expected to complete before the long-stop date of September 30, 2026.

  • ·No related party transaction; promoters have no interest.
  • ·Transaction to be funded by internal accruals and debt.
  • ·Board meeting held on April 27, 2026, from 2:00 PM to 2:35 PM.
Centrum Capital LimitedMerger/Acquisitionpositivemateriality 6/10

27-04-2026

Business Match Services (India) Private Limited, a promoter holding 13,44,99,041 equity shares (27.63%) in Centrum Capital Limited, reported the release of pledge on 15,00,000 shares (0.31% of total share capital) effective April 24, 2026, due to repayment of loan. This reduced the encumbered shares from 4,89,80,000 (10.06%) to 4,74,80,000 (9.15%). The disclosure was filed with BSE and NSE on April 27, 2026, under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

  • ·Disclosure under Regulation 31(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
  • ·CIN of Business Match Services: U74999MH1992PTC066170
  • ·Lender reference: MOHi Castings & Alloys (garbled in filing)
Mahindra Holidays & Resorts India LimitedMerger/Acquisitionpositivemateriality 8/10

27-04-2026

Mahindra Holidays & Resorts India Limited's Board approved the acquisition of 100% stake in Aditatva Estates Private Limited for ₹37.5 Crore on April 27, 2026, targeting a ~50 acre coffee plantation land in Chikmagalur, Karnataka, to develop a leisure resort. Aditatva's turnover remained nearly flat at Rs. 81,02,600 in FY2025 versus Rs. 80,61,845 in FY2024 (up ~0.5%), following a strong 117% growth from Rs. 37,09,649 in FY2023. The transaction, via cash under a Share Purchase Agreement, is expected to close by July 31, 2026, subject to conditions precedent, with Aditatva becoming a wholly owned subsidiary.

  • ·Aditatva date of incorporation: 30th November 2021
  • ·No governmental or regulatory approvals required
  • ·Not a related party transaction; no promoter interest
  • ·Country of presence: India
Global Health LimitedTakeoverpositivemateriality 8/10

27-04-2026

Global Health Limited (Medanta) plans to takeover an 80-bed Cancer Hospital in Indore, Madhya Pradesh, from Asian Institute of Oncology Private Limited via a Business Transfer Agreement for ₹30 Cr, including assignment of a long-term lease. The facility, strategically located 500 meters from Medanta's existing 175-bed multi-specialty hospital, will launch a comprehensive oncology program, enhance specialty offerings, and drive operational synergies. This expands Medanta's presence in Central India without any reported challenges or declines.

  • ·Network of six operational hospitals (Gurgaon, Indore, Ranchi, Lucknow, Patna, Noida) spanning 5.6 million sq. ft. as on December 31, 2025.
  • ·Five upcoming hospitals in Mumbai, Guwahati, Varanasi, and two in Delhi.
  • ·Healthcare services provided in over 30 medical specialties.
Arnold Holdings LtdMerger/Acquisitionneutralmateriality 3/10

27-04-2026

BSE has received a disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Khattu Hospitality Pvt Ltd in relation to Arnold Holdings Ltd. This filing indicates an intention by the acquirer to acquire shares or change shareholding that crosses specified thresholds under SAST, but no details on stake size, valuation, or transaction terms are provided. No quantitative financial impacts, deal structure, or timelines are disclosed.

Midwest LimitedMerger/Acquisitionneutralmateriality 3/10

27-04-2026

BSE has received a disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Midwest Ltd (BSE: 544587) pertaining to Kollareddy Ranganayakamma. The filing confirms compliance with SAST disclosure requirements for a substantial acquisition event. No quantitative details such as transaction value, shareholding changes, deal structure, or financial impact are provided.

Coffee Day Enterprises LimitedMerger/Acquisitionneutralmateriality 2/10

27-04-2026

BSE received a disclosure under Regulations 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Coffee Day Enterprises Ltd (539436) on April 27, 2026, pertaining to Coffee Day Consolidations Pvt Ltd. No specific details on shareholding changes, transaction values, percentages, or parties involved were mentioned in the filing. This is a regulatory compliance disclosure with no quantitative or material event data provided.

Cranex Ltd.Merger/Acquisitionneutralmateriality 5/10

27-04-2026

Cranex Ltd. (BSE: 522001) has made a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, received by BSE on April 27, 2026, pertaining to Chaitanya Agrawal and Persons Acting in Concert (PACs). This indicates a substantial acquisition or disposal of shares crossing disclosure thresholds, but no specific details on share count, percentage change, transaction value, or deal structure were provided in the filing. No financial metrics, valuations, or further transaction context were disclosed.

Get daily alerts with 12 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 39 filings

More from: India Sector Consolidation Regulatory Filings

🇮🇳 More from India

View all →